10.6084/m9.figshare.6808256.v1 Rosarin Sruamsiri Rosarin Sruamsiri Kosuke Iwasaki Kosuke Iwasaki Wentao Tang Wentao Tang Jรถrg Mahlich Jรถrg Mahlich Additional file 1: of Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database Springer Nature 2018 Psoriasis Biological therapy Persistence Medical costs Real-world data Claims database 2018-07-11 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Persistence_rates_and_medical_costs_of_biological_therapies_for_psoriasis_treatment_in_Japan_a_real-world_data_study_using_a_claims_database/6808256 Appendix A. ICD codes for disease to be excluded. Appendix B. Dosage regimen of included BTs. Appendix C. Gap definition (days) of included BTs in base case and sensitivity analysis (SA) 1 and 2. Appendix D. The rates of (number of persistent patients during the 12-month period after BT initiation/number of total patients) calculated in the base case and sensitivity analysis (SA) 1 and 2. (DOCX 23 kb)